These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11365491)

  • 1. ACTG 343: (why) we can't relax our grip on viral suppression.
    Maenza JR
    Hopkins HIV Rep; 1998 May; 10(3):10. PubMed ID: 11365491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTG 343: three drugs better than two for maintaining HIV suppression.
    Bowersox J
    NIAID AIDS Agenda; 1998 Mar; ():1-2, 10-1. PubMed ID: 11365088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
    Baker R
    BETA; 1997 Mar; ():3-4. PubMed ID: 11364527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final analysis of the Trilège induction-maintenance trial: results at 18 months.
    Flandre P; Raffi F; Descamps D; Calvez V; Peytavin G; Meiffredy V; Harel M; Hazebrouck S; Pialoux G; Aboulker JP; Brun Vezinet F
    AIDS; 2002 Mar; 16(4):561-8. PubMed ID: 11872999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient.
    Tachikawa N; Yasuoka A; Oka S
    Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
    Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
    An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
    Vigano A; Vella S; Saresella M; Vanzulli A; Bricalli D; Di Fabio S; Ferrante P; Andreotti M; Pirillo M; Dally LG; Clerici M; Principi N
    AIDS; 2000 Feb; 14(3):251-61. PubMed ID: 10716501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTG 320: last of the body count trials?
    PI Perspect; 1997 Mar; (No 21):7. PubMed ID: 11364215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 13. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 14. New study shows efavirenz effective with d4T and 3TC.
    AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials group: two studies are now open to patients who qualify.
    Craig K
    HIV Clin; 2000; 12(1):5. PubMed ID: 11810862
    [No Abstract]   [Full Text] [Related]  

  • 16. [HIV-therapy: as early and as intensive as possible].
    Dtsch Med Wochenschr; 1997 Oct; 122(41):A27. PubMed ID: 9378051
    [No Abstract]   [Full Text] [Related]  

  • 17. Protease inhibitors: major study stopped when 3-drug arm proves superior.
    AIDS Treat News; 1997 Mar; (No 266):7-8. PubMed ID: 11364247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine.
    Cahn P; Vibhagool A; Schechter M; Soto-Ramirez L; Carosi G; Smaill F; Jordan JC; Pharo CE; Thomas NE; Steel HM
    Curr Med Res Opin; 2004 Jul; 20(7):1115-23. PubMed ID: 15265256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.